Skip to main content

Table 1 Study inclusion and exclusion criteria

From: HIV-1 self-testing to improve the efficiency of pre-exposure prophylaxis delivery: a randomized trial in Kenya

Inclusion criteria

Exclusion criteria

▪ 18 years of age or older

▪ Less than 18 years old

â–ª Test HIV-1 negative (blood-based rapid HIV-1 test)

â–ª Test HIV-1 positive (blood-based rapid HIV-1 test)

â–ª Has been taking PrEP for at least 1 month prior to enrollment and planning to continue on PrEP

â–ª Not currently taking PrEP

â–ª Willing to be randomized to either clinic-based HIV-1 testing or at-home HIVST

â–ª Unwilling to be randomized to either clinic-based testing or at-home HIVST

â–ª Not currently enrolled in an HIV-1 prevention clinical trial

â–ª Enrolled in an HIV-1 prevention clinical trial

â–ª Contraindication to use of tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) or TDF/lamivudine (TDF/3TC)

â–ª Able and willing to provide written informed consent

â–ª Unable or unwilling to provide written informed consent

  1. Note that women who are pregnant or become pregnant during the study are still eligible for study participation
  2. HIV-1 human immunodeficiency virus-1, HIVST HIV-1 self-testing, PrEP pre-exposure prophylaxis